Virtual Tour
![](http://www.qvella.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![](http://www.qvella.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![](http://www.qvella.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
Click through the sliders to learn more about the system.
![](http://www.qvella.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![](http://www.qvella.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![](http://www.qvella.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![](http://www.qvella.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![](http://www.qvella.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![](http://www.qvella.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![](http://www.qvella.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![](http://www.qvella.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![](http://www.qvella.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![](http://www.qvella.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![](http://www.qvella.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![](http://www.qvella.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![](http://www.qvella.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![](http://www.qvella.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![](http://www.qvella.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
Webinars
![ondemandheadshot](https://www.qvella.com/wp-content/uploads/2022/04/ondemandheadshot.png)
Episode 5 – On Demand
The FAST™ System has the Potential to Expedite ID & AST for Bloodborne Pathogens from Positive Blood Cultures
David Pride, MD, PhD, Infectious Disease Specialist, UC San Diego Health
![Dr_Haake-BW](https://www.qvella.com/wp-content/uploads/2021/10/Dr_Haake-BW-1.jpg)
Episode 4 – On Demand
Impact of reducing time to results in septic patient management
Dr. David Haake, Chief Medical Officer, Qvella
![dalpke-photo-BW 1](https://www.qvella.com/wp-content/uploads/2021/09/dalpke-photo-BW-1.png)
Episode 3 – On Demand
Saving time in microbiological blood culture diagnostics
Prof. Dr. med. Alexander Dalpke (TU Dresden)
![speaker2](https://www.qvella.com/wp-content/uploads/2021/08/speaker2.png)
Episode 2 – On Demand
Reduce time from PBC to actionable results by generating a Liquid Colony™
Herbert Torfs, PhD, V.P. of Business Development EMEA, Qvella and Professor Alexia Verroken, MD, PhD, Clinical Microbiologist, Saint-Luc University Hospital
![speaker1](https://www.qvella.com/wp-content/uploads/2021/08/speaker1.png)
Episode 1 – On Demand
A New Paradigm in Positive Blood Culture Processing
Susan Novak-Weekley, PhD, D(ABMM), S(M) ASCP
Vice President of Medical Affairs, Qvella
![Group 37](https://www.qvella.com/wp-content/uploads/2022/05/Group-37-1.png)
Lisbon
Evaluation of a Novel Sample Preparation Method for Rapid Antimicrobial Resistance Testing Directly from Positive Blood Cultures.
![Group 37](https://www.qvella.com/wp-content/uploads/2022/05/Group-37-1.png)
Lisbon
Comparison of a Novel Sample Preparation Method for Positive Blood Cultures vs. Standard of Care Overnight Sub-Culture: 0.5 McFarland Cell Concentrations and Antimicrobial Susceptibility Test Results.
![Group 37](https://www.qvella.com/wp-content/uploads/2022/05/Group-37-1.png)
Lisbon
A Novel Sample Preparation Method for Positive Blood Cultures: Assessment of Sample Stability for Downstream Identification and Antimicrobial Susceptibility Testing.
![asm-2021-poster](https://www.qvella.com/wp-content/uploads/2021/08/asm-2021-poster.png)
San Diego
Analysis of the FAST™ System for expedited identification and susceptibilities of bloodborne pathogens.
![eccmid-poster-2](https://www.qvella.com/wp-content/uploads/2021/08/eccmid-poster-2.png)
Belgium
Performances of the FAST™ System enabling speeded-up positive blood culture ID/AST results using Bruker MALDI-TOF MS< BD Phoenix and disk diffusion.
![eccmid-poster-2](https://www.qvella.com/wp-content/uploads/2021/08/eccmid-poster-2.png)
Florence
Evaluation of the FAST™ System: an automated and rapid system for isolating microbial cells from positive blood culture.
![eccmid-poster-2](https://www.qvella.com/wp-content/uploads/2021/08/eccmid-poster-2.png)
Dresden
Evaluation of the FAST™ System (Qvella) for accelerated species identification and antimicrobial susceptibility testing from positive blood culture bottles using the Bruker MALDI and bioMerieux Vitek 2.
FAST™ System and FAST PBC Prep Cartridge have received CE marking for in-vitro diagnostic (IVD) use in Europe (as per EU IVDR 2017/746) and are now listed as Class I IVD devices with the US FDA.
These devices have not been validated for any downstream diagnostic applications and are only indicated for positive blood culture specimens containing bacteria.